Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label
Par un écrivain mystérieux
Description
Immunogenicity and safety of a quadrivalent meningococcal tetanus
Long-term antibody persistence after a booster dose of
Safety and immunogenicity of an investigational quadrivalent
PDF] Immunogenicity and safety of an investigational
PDF] Immunogenicity and safety of an investigational
PDF) Immunogenicity and safety of a booster dose of a quadrivalent
Prevention and Control of Meningococcal Disease
Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali
Vaccines, Free Full-Text
Safety, immunogenicity, and immune memory of a novel meningococcal
Structured Benefit-Risk Assessment of a New Quadrivalent
Structured Benefit-Risk Assessment of a New Quadrivalent
Microorganisms, Free Full-Text
Immunogenicity and safety of a quadrivalent meningococcal tetanus
depuis
par adulte (le prix varie selon la taille du groupe)